Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Zhai, YF; Tang, QQ; Fang, DD; Deng, J; Zhang, KX; Wang, QX; Yin, Y; Fu, CC; Xue, SL; Li, N; Zhou, F; Yang, DJ

Zhai, YF (通讯作者)，Ascentage Pharm Suzhou Co Ltd, 68 Xinqing Rd, Suzhou, Jiangsu, Peoples R China.

CLINICAL CANCER RESEARCH, 2023; 29 (1): 183

Abstract

Purpose: Despite approval of B-cell lymphoma (BCL)-2 inhib-itor venetoclax for certain hematologic malignancies, its broader clinical benefit is curta......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索